小鼠模型市场:现状分析与预测(2022-2030年)

随着基因工程技术的进步，开发出更精确的小鼠模型，使研究人员能够更好地模拟人类疾病并测试潜在的治疗方法，小鼠模型市场增长迅速，预计稳定增长约8%。市场主要参与者从事产品改进和研究活动，这有利于市场的增长。

为了更好的了解鼠标模型行业的市场介绍，将市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、意大利、欧洲其他地区） 、亚太地区（中国、日本、印度、亚太地区其他地区）和世界其他地区。由于主要生物技术和製药公司以及学术研究机构的存在，预计北美将占据小鼠模型市场的最大占有率。药物开发对小鼠模型的需求不断增加，以及癌症和心血管疾病等慢性疾病的流行正在推动市场增长。例如，根据美国癌症协会（ACS）发布的数据，2020年1月，美国新诊断出约180万癌症病例，并有606,520人因癌症死亡。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对小鼠模型市场带来的影响

第6章 小鼠模型的市场收益，2020-2030年

第7章 市场洞察:鼠标类别

• 近交类
• 异系交配
• 基因剔除
• 混合
• 其他

第8章 市场洞察:各技术

• 基因编辑技术
• 显微注射
• 胚胎干细胞注射
• 核转移
• 其他

第9章 市场洞察:各用途

• 药物研发与开发
• 研究中心
• PDx模式/异质骨移植

第10章 市场洞察:各终端用户

• 学术研究所及研究中心
• 製药公司及生物科技企业
• CRO和CMO
• 其他

第11章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 全球其他地区

第12章 小鼠模型市场动态

• 推动市场要素
• 市场课题
• 影响分析

第13章 小鼠模型市场机会

第14章 小鼠模型市场趋势

第15章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第16章 价值链分析

第17章 价格分析

第18章 策略性洞察能力

第19章 竞争模式

• 竞争情形
  • 波特的五力分析

第20章 企业简介

• Envigo Marketing Private Limited
• Laboratory Corporation of America(R)Holdings
• Janvier Labs
• Harbour Antibodies Bv
• Charles River Laboratories
• THE JACKSON LABORATORY
• Taconic Biosciences, Inc.
• genOway
• Horizon Discovery Ltd., Company
• ingenious targeting laboratory

第21章 免责声明

Mice models, known as genetically modified mice, are living organisms that have been genetically modified to exhibit specific characteristics that mimic human diseases. These models are widely used in medical research to study mechanisms of diseases, test potential therapies, and develop new treatments. Mice models play a crucial role in drug discovery and help researchers to better understand disease pathways that are safe and effective for humans. There are several growth factors that will drive the market such as the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases. Mice models provide researchers with a way to study these complex diseases and develop new treatments. For instance, as per American Heart Association (AHA), coronary heart disease causes 1 in every 7 deaths in the U.S., resulting in about 366,800 deaths each year. In addition, in 2020, there were 2.2 million new cases of lung cancer reported.

The mice model market is expected to grow at a steady rate of around 8% owing to the advancement of genetic engineering technologies has led to the development of more accurate and precise mice models, enabling researchers to better mimic human diseases and test potential therapies. Major companies in the market are working on product advancement and research activities which is beneficial for the growth of this market. For instance, in Europe, Taconic Biosciences began producing humanized immune system mouse models in February 2020. This extended the organization's assembling limit as well as its client base in Europe.

Based on mice type, the market is segmented into inbred, outbred, knockout, hybrid, and others. Amongst them, the inbred category is to witness higher CAGR during the forecast period owing to the inbred model type being expected to dominate the market due to its stable genetic makeup and reproducibility. The knockout model type is also expected to grow significantly due to its ability to mimic human diseases and study gene function.

On the basis of technology, the market is categorized into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and others. Among these, the CRISPR/Cas9 technology is expected to hold the largest share of the market due to its high precision and efficiency in gene editing. The embryonic stem cell injection technology is also expected to grow significantly due to its ability to generate genetically modified mice models.

Based on application, the mice model market has been classified into drug discovery & development, research centers, and pdx models/xenograft. The drug discovery & development category is to witness higher adoption of the mice model during the forecast period. The mice model market is closely linked to the drug discovery and development process, as mice models are widely used in preclinical studies to test potential therapies and understand drug mechanisms of action. Mice models provide a platform to study human diseases and understand disease mechanisms, which is critical for the development of new treatments.

Based on end-user, the mice model market has been classified into academics institute & research centers, pharmaceutical & biotech companies, CROs and CMOs, and others. The academic and research institutions category held the largest share of the market in 2021 owing to the increasing demand for mice models in academic research. Mice models provide a platform to study human diseases and understand disease mechanisms. Additionally, mice models are used to develop new treatments for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.

For a better understanding of the market adoption of the mice model industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to hold the largest share of the mice model market due to the presence of leading biotechnology and pharmaceutical companies and academic research institutions in the region. The increasing demand for mice models in drug development and the growing prevalence of chronic diseases, such as cancer and cardiovascular diseases, are driving market growth. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States.

Some of the major players operating in the market include: Envigo Marketing Private Limited; Laboratory Corporation of America® Holdings; Janvier Labs; Harbour Antibodies Bv; Charles River Laboratories; THE JACKSON LABORATORY; Taconic Biosciences, Inc.; genOway; Horizon Discovery Ltd., Company; and ingenious targeting laboratory

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Mice Model Market
• 2.2. Research Methodology of the Mice Model Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MICE MODEL MARKET

6 MICE MODEL MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY MICE TYPE

• 7.1. Inbred
• 7.2. Outbred
• 7.3. Knockout
• 7.4. Hybrid
• 7.5. Others

8 MARKET INSIGHTS BY TECHNOLOGY

• 8.1. CRISPR
• 8.2. Microinjection
• 8.3. Embryonic Stem Cell Injection
• 8.4. Nuclear Transfer
• 8.5. Others

9 MARKET INSIGHTS BY APPLICATION

• 9.1. Drug Discovery & Development
• 9.2. Research Centers
• 9.3. PDx Models/Xenograft

10 MARKET INSIGHTS BY END-USER

• 10.1. Academics Institute & Research Centers
• 10.2. Pharmaceutical & Biotech Companies
• 10.3. CROs and CMOs
• 10.4. Others

11 MARKET INSIGHTS BY REGION

• 11.1. North America
  • 11.1.1. U.S.
  • 11.1.2. Canada
  • 11.1.3. Rest of North America
• 11.2. Europe
  • 11.2.1. Germany
  • 11.2.2. U.K.
  • 11.2.3. France
  • 11.2.4. Italy
  • 11.2.5. Spain
  • 11.2.6. Rest of Europe
• 11.3. Asia-Pacific
  • 11.3.1. China
  • 11.3.2. Japan
  • 11.3.3. India
  • 11.3.4. Rest of Asia-Pacific
• 11.4. Rest of World

12 MICE MODEL MARKET DYNAMICS

• 12.1. Market Drivers
• 12.2. Market Challenges
• 12.3. Impact Analysis

13 MICE MODEL MARKET OPPORTUNITIES

14 MICE MODEL MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

• 19.1. Competitive Landscape
  • 19.1.1. Porters Fiver Forces Analysis

20 COMPANY PROFILED

• 20.1. Envigo Marketing Private Limited
• 20.2. Laboratory Corporation of America® Holdings
• 20.3. Janvier Labs
• 20.4. Harbour Antibodies Bv
• 20.5. Charles River Laboratories
• 20.6. THE JACKSON LABORATORY
• 20.7. Taconic Biosciences, Inc.
• 20.8. genOway
• 20.9. Horizon Discovery Ltd., Company
• 20.10. ingenious targeting laboratory

21 DISCLAIMER